Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

45

Revenue 2017

Zytiga

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zytiga was produced by Janssen.

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer Johnson &Johnson’s Zytiga (abiraterone) or Pfizer’s Xtandi (enzalutamide).

Litigation concerns threaten to overshadow solid quarter at J&J

Litigation concerns threaten to overshadow solid quarter at J&J therapy Zytiga (abiraterone acetate).

Lynparza scores another positive phase 3 prostate cancer study

Lynparza scores another positive phase 3 prostate cancer study Zytiga (abiraterone acetate) or Pfizer’s Xtandi (enzalutamide). ... The drug was compared to Xtandi or Zytiga in the second-line setting, and also focused on patients with HRRm gene mutations.

J&J puts pressure on rivals with new Erleada okay in prostate cancer

J&J puts pressure on rivals with new Erleada okay in prostate cancer Androgen inhibitor Erleada (apalutamide) is J&J’s follow-up up to big-selling prostate cancer therapy Zytiga (abiraterone acetate), which has been in a market battle for years with Xtandi ... and Pfizer’s drug as it tries to position Erleada as a

Trial backs role for Lynparza in second-line prostate cancer

Trial backs role for Lynparza in second-line prostate cancer In the 340-patient trial,   Lynparza was compared to hormonal treatment with Pfizer’s Xtandi (enzalutamide) or Johnson &Johnson’s Zytiga (abiraterone acetate) in this second-line setting, focusing on patients ... AZ is also conducting a phase 3

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...